Correction: Neratinib: Inching up on the cure rate of HER2 þ breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the original version of this article (1), the stated disclosure of the author Carlos L. Arteaga is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.

Original languageEnglish (US)
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number4
DOIs
StatePublished - Feb 15 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction: Neratinib: Inching up on the cure rate of HER2 <sup>þ</sup> breast cancer? (Clin Cancer Res) (2019) 24 (3483–3485) Doi: 10.1158/1078-0432.CCR-18-1114)'. Together they form a unique fingerprint.

Cite this